1-4 of 4
Charles T. Esmon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C

Miao Jiang, Fei Yang, Yizhi Jiang, Lu Cheng, Jingjing Han, Jiawei Yi, Guige Zhang, Zhenni Ma, Lijuan Cao, Bin Zuo, Lixia Zhou, Lulu Huang, Siying Niu, Zhisong Xia, Xuefeng Zhou, Xia Bai, Naomi L. Esmon, Changgeng Ruan, Lijun Xia, Yue Han, Charles T. Esmon, Depei Wu, Jun Xu
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3304–3314.
https://doi.org/10.1182/bloodadvances.2021006214
Published: 2022
Includes: Supplemental data
Journal Articles

An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice

Bilgimol Chumappumkal Joseph, Byron Y. Miyazawa, Charles T. Esmon, Mitchell J. Cohen, Annette von Drygalski, Laurent O. Mosnier
Journal: Blood Advances
Blood Adv (2022) 6 (3): 959–969.
https://doi.org/10.1182/bloodadvances.2021005257
Published: 2022
Includes: Supplemental data
Journal Articles

ICAM-1–targeted thrombomodulin mitigates tissue factor–driven inflammatory thrombosis in a human endothelialized microfluidic model

Colin F. Greineder, Ian H. Johnston, Carlos H. Villa, Kandace Gollomp, Charles T. Esmon, Douglas B. Cines, Mortimer Poncz, Vladimir R. Muzykantov
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1452–1465.
https://doi.org/10.1182/bloodadvances.2017007229
Published: 2017
Includes: Multimedia, Supplemental data
Journal Articles

Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: mode of its action

Shiva Keshava, Jagan Sundaram, Anuradha Rajulapati, Charles T. Esmon, Usha R. Pendurthi, L. Vijaya Mohan Rao
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1206–1214.
https://doi.org/10.1182/bloodadvances.2016004143
Published: 2017